1994Birkhäuser Boston eBooksRequires access

Endogenous MPTP-Like Amines in the Brain: Isoquinolines

Toshiharu Nagatsu, Makoto Naoi, Toshimitsu Niwa, Mitsuo Yoshida

Open publisher page 1 citations

Abstract

The discovery of N -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a parkinsonism-producing neurotoxin (Davis et al., 1979; Langston et al., 1983) has greatly contributed to the pathogenesis of Parkinson’s disease. Efforts have been made to find MPTP-like neurotoxins in the brain of parkinsonian patients. MPTP is a precursor neurotoxin, and the oxidized form, by monoamine oxidase type B, N -methyl-4-phenylpyridinium ion (MPP + ), is the active neurotoxin (Chiba et al., 1984). It is assumed, therefore, that if any hypothetical MPTP-like neurotoxins exist in the parkinsonian brain they might be oxidized by monoamine oxidase to active neurotoxins. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

About this research paper

What this paper is about

The discovery of N -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a parkinsonism-producing neurotoxin (Davis et al., 1979; Langston et al., 1983) has greatly contributed to the pathogenesis of Parkinson’s disease. Efforts have been made to find MPTP-like neurotoxins in the brain of parkinsonian patients. MPTP is a precursor neurotoxin, and the oxidized form, by monoamine oxidase type B, N -methyl-4-phenylpyridinium ion (MPP + ), is the active neurotoxin (Chiba et al., 1984). It is assumed, therefore, that if any hypothetical MPTP-like neurotoxins exist in the parkinsonian brain they might be oxidized by monoamine oxidase to active neurotoxins. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The discovery of N -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a parkinsonism-producing neurotoxin (Davis et al., 1979; Langston et al., 1983) has greatly contributed to the pathogenesis of Parkinson’s disease. Efforts have been made to find MPTP-like neurotoxins in the brain of parkinsonian patients. MPTP is a precursor neurotoxin, and the oxidized form, by monoamine oxidase type B, N -methyl-4-phenylpyridinium ion (MPP + ), is the active neurotoxin (Chiba et al., 1984). It is assumed, therefore, that if any hypothetical MPTP-like neurotoxins exist in the parkinsonian brain they might be oxidized by monoamine oxidase to active neurotoxins. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Key concepts: MPTP, Neurotoxin, Monoamine oxidase, Parkinsonism, Chemistry, Monoamine oxidase B, Pharmacology, Neuroscience

Related papers

Back to paper searchBrowse research topicsOriginal source
Endogenous MPTP-Like Amines in the Brain: Isoquinolines — Research Paper | ScholarLens